Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Non-Current Assets (2020 - 2025)

Sotera Health (SHC) has 6 years of Non-Current Assets data on record, last reported at $2.6 billion in Q3 2025.

  • For Q3 2025, Non-Current Assets rose 0.9% year-over-year to $2.6 billion; the TTM value through Sep 2025 reached $7.2 billion, down 29.59%, while the annual FY2024 figure was $2.5 billion, 1.07% down from the prior year.
  • Non-Current Assets reached $2.6 billion in Q3 2025 per SHC's latest filing, up from -$555.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.6 billion in Q3 2025 and bottomed at -$555.0 million in Q1 2025.
  • Average Non-Current Assets over 5 years is $1.7 billion, with a median of $2.5 billion recorded in 2022.
  • Peak YoY movement for Non-Current Assets: surged 808.53% in 2022, then plummeted 121.57% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $2.4 billion in 2021, then grew by 1.19% to $2.5 billion in 2022, then grew by 4.06% to $2.6 billion in 2023, then fell by 1.07% to $2.5 billion in 2024, then rose by 2.46% to $2.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $2.6 billion in Q3 2025, -$555.0 million in Q1 2025, and $2.5 billion in Q4 2024.